Wird geladen...
Low prevalence of bone mineral density testing in patients with systemic lupus erythematosus and glucocorticoid exposure
Patients with systemic lupus erythematosus (SLE) have an increased risk of developing osteoporosis and fractures due to systemic inflammation and glucocorticoids (GCs). Professional organizations recommend bone mineral density (BMD) testing in SLE patients on GCs, especially within 6 months of initi...
Gespeichert in:
| Veröffentlicht in: | Lupus |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2020
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7933066/ https://ncbi.nlm.nih.gov/pubmed/33307984 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0961203320979735 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|